Gender Male
Bret L. MacPherson, M.S., Vice President of Operations. Mr. MacPherson brings diverse business and development experience to manage ITI’s day-to-day operations. For the past 11 years, he has worked primarily in clinical development, most recently as Director, Clinical Affairs at Cytokine PharmaSciences, Inc., the licensor of ITI’s core intellectual
property. As such, Mr. MacPherson comes to ITI with a working knowledge of this anti-viral technology and experience developing similar compounds.
In 1986, Mr. MacPherson began his career in sales, training and marketing with SmithKline Beecham Pharmaceuticals. From SmithKline he moved on to Centocor, where his responsibilities shifted from the
commercialization effort to clinical development. Mr. MacPherson furthered his experience at Cell Therapeutics, a Seattle-based biotech concern. While at Cell Therapeutics, Mr. MacPherson managed clinical trials in oncology and inflammatory diseases.
Mr. MacPherson provides ITI with proven project management experience, especially with contract research organizations. He has participated in the submission of 4 IND applications and has worked on the development of 6 therapeutic drugs. Mr. MacPherson has Bachelor’s and Master’s of Science degrees from the University of Oregon.
